27 false false false false false false false false false false true false false false false false false No description of principal activity 2023-01-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 07151288 2023-01-01 2024-03-31 07151288 2024-03-31 07151288 2022-12-31 07151288 2022-01-01 2022-12-31 07151288 2022-12-31 07151288 2021-12-31 07151288 bus:Director1 2023-01-01 2024-03-31 07151288 core:LandBuildings core:LongLeaseholdAssets 2024-03-31 07151288 core:LandBuildings core:LongLeaseholdAssets 2023-01-01 2024-03-31 07151288 core:WithinOneYear 2024-03-31 07151288 core:WithinOneYear 2022-12-31 07151288 core:ShareCapital 2024-03-31 07151288 core:ShareCapital 2022-12-31 07151288 core:CapitalRedemptionReserve 2024-03-31 07151288 core:CapitalRedemptionReserve 2022-12-31 07151288 core:RetainedEarningsAccumulatedLosses 2024-03-31 07151288 core:RetainedEarningsAccumulatedLosses 2022-12-31 07151288 bus:SmallEntities 2023-01-01 2024-03-31 07151288 bus:AuditExemptWithAccountantsReport 2023-01-01 2024-03-31 07151288 bus:SmallCompaniesRegimeForAccounts 2023-01-01 2024-03-31 07151288 bus:PrivateLimitedCompanyLtd 2023-01-01 2024-03-31 07151288 bus:FullAccounts 2023-01-01 2024-03-31 07151288 core:ComputerEquipment 2022-12-31 07151288 core:ComputerEquipment 2023-01-01 2024-03-31 07151288 core:ComputerEquipment 2024-03-31
COMPANY REGISTRATION NUMBER: 07151288
CLOCKTOWER HEALTHCARE LTD
FILLETED UNAUDITED FINANCIAL STATEMENTS
31 March 2024
CLOCKTOWER HEALTHCARE LTD
STATEMENT OF FINANCIAL POSITION
31 March 2024
31 Mar 24
31 Dec 22
Note
£
£
£
Fixed assets
Tangible assets
5
31,300
4,433
Current assets
Debtors
6
138,293
387,531
Cash at bank and in hand
694,499
1,907,402
---------
------------
832,792
2,294,933
Creditors: amounts falling due within one year
7
335,652
1,915,899
---------
------------
Net current assets
497,140
379,034
---------
---------
Total assets less current liabilities
528,440
383,467
---------
---------
Net assets
528,440
383,467
---------
---------
Capital and reserves
Called up share capital
200
200
Capital redemption reserve
9,800
9,800
Profit and loss account
518,440
373,467
---------
---------
Shareholders funds
528,440
383,467
---------
---------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
For the period ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
CLOCKTOWER HEALTHCARE LTD
STATEMENT OF FINANCIAL POSITION (continued)
31 March 2024
These financial statements were approved by the board of directors and authorised for issue on 27 March 2025 , and are signed on behalf of the board by:
Dr C Anggiansah
Director
Company registration number: 07151288
CLOCKTOWER HEALTHCARE LTD
NOTES TO THE FINANCIAL STATEMENTS
PERIOD FROM 1 JANUARY 2023 TO 31 MARCH 2024
1. General information
The company is a private company limited by shares, registered in United Kingdom. The address of the registered office is Numeric House, 98 Station Road, Sidcup, Kent, DA15 7BY, England.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Debtors
Debtors are initially recorded at fair value and are assessed for impairment at each year end date. If any impairments exist the debtors are re-measured to the present value of the expected future cash inflows.
Creditors
Creditors are initially recorded at fair value and are then remeasured to the present value of the expected future cash outflows.
Revenue recognition
Turnover is measured a the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Operating leases
Lease payments are recognised as an expense over the lease term on a straight-line basis. The aggregate benefit of lease incentives is recognised as a reduction to expense over the lease term, on a straight-line basis.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Equipment
-
33% Reducing Balance
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets.
Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
4. Employee numbers
The average number of persons employed by the company during the period amounted to 27 (2022: 40 ).
5. Tangible assets
Long leasehold property
Equipment
Total
£
£
£
Cost
At 1 January 2023
5,132
5,132
Additions
28,053
1,093
29,146
--------
-------
--------
At 31 March 2024
28,053
6,225
34,278
--------
-------
--------
Depreciation
At 1 January 2023
699
699
Charge for the period
2,279
2,279
--------
-------
--------
At 31 March 2024
2,978
2,978
--------
-------
--------
Carrying amount
At 31 March 2024
28,053
3,247
31,300
--------
-------
--------
At 31 December 2022
4,433
4,433
--------
-------
--------
6. Debtors
31 Mar 24
31 Dec 22
£
£
Trade debtors
131,831
139,690
Other debtors
6,462
247,841
---------
---------
138,293
387,531
---------
---------
7. Creditors: amounts falling due within one year
31 Mar 24
31 Dec 22
£
£
Trade creditors
83,657
114,316
Corporation tax
89,028
31,558
Social security and other taxes
6,463
7,208
Clocktower PCN
1,726,436
Other creditors
156,504
36,381
---------
------------
335,652
1,915,899
---------
------------
8. Pensions
The scheme is an unfunded, defined benefit scheme that covers the NHS employer, general practices and other bodies, allowed under the direction of the Secretary of State for Health, England & Wales. The scheme is not designed to be run in a way that would enable employing bodies to identify their share of the underlying scheme assets and liabilities. Therefore, the scheme is accounted for as if it were a defined contribution scheme. The cost to the employer of participating in the scheme is taken as as equal to the contributions payable to the scheme for the accounting period.
Those contributions are recognised as an expense in profit or loss when they fall due. This is categorised under direct costs as 'Employer superannuation'. Amounts not paid are shown as a liability in the balance sheet.
9. Operating leases
The total future minimum lease payments under non-cancellable operating leases are as follows:
31 Mar 24
31 Dec 22
£
£
Not later than 1 year
64,500
64,500
--------
--------
10. Directors' advances, credits and guarantees
The overdrawn directors' loan accounts balance of £205,834 was brought forward from 2022. Repayments totalling £100,529 each were made by M Patel and C Anggiansah. The remaining balances of £2,388 and £2,388 respectively were outstanding at the year end and are repayable on demand. The total debtor of £4,775 is shown in other debtors. The associated S455 tax recoverable is also shown in other debtors.